Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: on-treatment kinetics of HBsAg serum levels vary by HBV genotype.
J Hepatol
; 59(6): 1153-9, 2013 Dec.
Article
em En
| MEDLINE
| ID: mdl-23872601
Palavras-chave
ALT; CHB; EOT; Genotype; HBV; HBeAg; HBeAg-negative chronic hepatitis B; HBsAg; HBsAg quantification; IFN; LVR; NPV; PPV; Peginterferon alfa-2a; ROC; Response-guided; alanine aminotransferase; chronic hepatitis B; end-of-treatment; hepatitis B e antigen; hepatitis B s antigen; hepatitis B virus; interferon; long-term virological response; negative predictive value; positive predictive value; receiver-operating characteristic
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Antivirais
/
Polietilenoglicóis
/
Vírus da Hepatite B
/
Interferon-alfa
/
Hepatite B Crônica
/
Antígenos E da Hepatite B
/
Antígenos de Superfície da Hepatite B
Tipo de estudo:
Prognostic_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article